Regulations.gov document
Reference 7 - Information for Blood Establishments Regarding FDA’s Determination that Zika…
Supporting & Related Material · FDA-2024-D-1244 · posted Apr 30, 2024
Key facts
| Document ID | FDA-2024-D-1244-0009 |
|---|---|
| Title | Reference 7 - Information for Blood Establishments Regarding FDA’s Determination that Zika Virus is no Longer a Relevant Transfusion-Transmitted Infection, and Withdrawal of Guidance titled “Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components”, May 12, 2021, https://www.fda.gov/media/148549/download. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2024-D-1244 |
| Posted | Apr 30, 2024 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: